Discovery of a new family of bis-8-hydroxyquinoline substituted benzylamines with pro-apoptotic activity in cancer cells: synthesis, structure-activity relationship, and action mechanism studies.
Bis-8-hydroxyquinoline substituted benzylamines have been synthesized and screened for their antitumor activity on KB3 cell line model. Synthesis of this series of new analogues was accomplished using a one pot specific methodology which allows the synthesis of both bis- and mono-8-hydroxyquinoline substituted benzylamines. Among the synthesized compounds two compounds (4a and 5a), respectively, named JLK 1472 and JLK 1486, were particularly potent on KB3 cell line. Their CC(50) values being, respectively, 2.6 and 1.3 nM. Screened on a panel of cell lines showing various phenotype alterations, both compounds were found inactive on some cell lines such as PC3 (prostate cell line) and SF268 (neuroblastoma cell line) while highly active on other different cell lines. Mechanistic studies reveal that these two analogues did not affect tubulin and microtubules neither they exert a proteasomal inhibition effect. In contrast 4a and 5a activate specifically caspase 3/7 and not caspase 8 and 9, suggesting that their biological target should be located upstream from caspase 3/7. Moreover their cytotoxic effect is potentiated by the pro-apoptotic effects of TRAIL.
Moret
Vincent
V
Laboratoire de Chimie Biomoléculaire, IBDML-UMR-6216-CNRS, Faculté des Sciences Luminy, Université de la Méditerranée, Parc Scientifique de Luminy, Case 901, 13288 Marseille Cedex 9, France.
Laras
Younes
Y
Cresteil
Thierry
T
Aubert
Geneviève
G
Ping
Dou Q
DQ
Di
Chen
C
Barthélémy-Requin
Magali
M
Béclin
Christophe
C
Peyrot
Vincent
V
Allegro
Diane
D
Rolland
Amandine
A
De Angelis
Francesca
F
Gatti
Evelina
E
Pierre
Philippe
P
Pasquini
Luca
L
Petrucci
Eleonora
E
Testa
Ugo
U
Kraus
Jean-Louis
JL
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D001596:Benzylamines / Q000138:chemical synthesis* / Q000494:pharmacology; D020169:Caspases / Q000187:drug effects; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines; D008297:Male; D013329:Structure-Activity Relationship; D053221:TNF-Related Apoptosis-Inducing Ligand
D000970:Antineoplastic Agents; D001596:Benzylamines; D006912:Hydroxyquinolines; D053221:TNF-Related Apoptosis-Inducing Ligand; D020169:Caspases